Global Spine Biologics Market to Grow at a CAGR of 2.07% During 2016-2020
The global spine biologics market has seen an ideal shift in the past few years. The market is witnessing growth because of the developments and adoption of spine biologic by end-users. The market is driven by factors such as the increase in older adult population and growing incidence of spinal disorders such as herniated discs, degenerative disc disease, spondylolisthesis, prolapsed intervertebral disc, and spinal stenosis. A shift in preference for MI surgeries over open surgeries has led to the development...
View full press release